Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrolide resistance.

B Weisblum1

  • 1Department of Pharmacology, University of Wisconsin Medical School, Madison, Wisconsin 53706, USA. weisblum@macc.wisc.edu

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|November 10, 2006
PubMed
Summary

Bacteria have evolved resistance to macrolide antibiotics through four generations, with mechanisms changing from inducible to constitutive resistance and rRNA alterations. Understanding these resistance pathways is crucial for developing new antibiotics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peptide analogues of the VanS catalytic center inhibit VanR binding to its cognate promoter.

Biochemistry·2000
Same author

Modulation of erm methyltransferase activity by peptides derived from phage display.

Antimicrobial agents and chemotherapy·2000
Same author

Non-haemolytic beta-amino-acid oligomers.

Nature·2000
Same author

Back to Camelot: defining the specific role of tRNA in protein synthesis.

Trends in biochemical sciences·1999
Same author

Dissecting the VanRS signal transduction pathway with specific inhibitors.

Journal of bacteriology·1999
Same author

Essential role of endogenously synthesized tylosin for induction of ermSF in Streptomyces fradiae.

Antimicrobial agents and chemotherapy·1997

Area of Science:

  • Microbiology
  • Pharmacology
  • Molecular Biology

Background:

  • Macrolide antibiotics, starting with erythromycin in 1952, have undergone four generations of chemical evolution.
  • Early macrolides induced bacterial resistance, leading to the development of second and third generations with altered resistance profiles and improved pharmacokinetics.
  • Third-generation macrolides, used for infections like Helicobacter pylori and Mycobacterium tuberculosis, selected for intrinsically resistant strains with rRNA structural changes.

Purpose of the Study:

  • To review the biochemical and genetic mechanisms of bacterial resistance to the first three generations of macrolide antibiotics.
  • To explain the evolution of macrolide resistance, including inducible, constitutive, and rRNA-mediated mechanisms.
  • To provide insights into the development of resistance against macrolide antibiotics.

Main Methods:

  • Review of existing literature on macrolide antibiotic resistance.
  • Analysis of biochemical pathways involved in bacterial resistance.
  • Examination of genetic regulation mechanisms of resistance expression.

Main Results:

  • First-generation macrolides (erythromycin) induced resistance, which was overcome by second-generation macrolides.
  • Second-generation macrolides selected for constitutive resistance through target strain mutation.
  • Third-generation macrolides, with improved pharmacokinetics, led to intrinsically resistant strains with rRNA alterations, where low rRNA gene copy number facilitated resistance expression.

Conclusions:

  • Bacterial resistance to macrolides is a dynamic process involving diverse biochemical and genetic strategies.
  • Understanding the evolutionary trajectory of macrolide resistance is essential for guiding the development of effective antimicrobial therapies.
  • The emergence of resistance highlights the need for continued research into novel antibiotic classes and resistance-breaking strategies.

Related Experiment Videos